maps

Is the High Cost of Psychedelic Therapy Worth It?
MAPS Found Liable in Wrongful Death Lawsuit
Will the Psychedelic Revolution Be Medicalized?
Psychedelic Therapy Training Programs Expand To Meet Demand
MAPS Publishes Open Science Approach to Synthesizing MDMA
Psychedelic-Assisted Therapy on the Rise in VA Hospitals
Can a Values-Centered Psychedelic Ecosystem Effectively Compete?
Rick Doblin Explains MAPS’ New $70 Million Investment Fund With Vine Ventures
In Defense of Ketamine: Five Questions For Ismail Lourido Ali of MAPS
Denver Launches the Nation’s First Psychedelic Harm Reduction Training for First Responders